Giacchino J L, Geis W P, Buckingham J M, Vertuno L L, Bansal V K
Arch Surg. 1979 Apr;114(4):403-9. doi: 10.1001/archsurg.1979.01370280057008.
Effective approaches to unique problems of vascular access in renal failure have evolved from a five-year experience with 840 angioaccess procedures. Standard techniques plus innovations have required only 0.62 operations per year per patient with an average access life of 1.6 years. Classical forearm external arteriovenous (AV) cannulas and internal AV fistulas provided vascular access in 392 patients, while 61 required more complex procedures due to failure of primary cannulas and fistulas, inherently small forearm vessels, and iatrogenic vessel loss. Secondary techniques include reverse fistula, vascular graft AV fistulas using expanded polytetrafluoroethylene (E-PTFE), and arterioarterial (AA) jump graft. Presently, the new renal failure patient receives a forearm radiocephalic AV fistula; the cannula is restricted to emergency or short-term hemodialysis and may later be converted to a subcutaneous fistula. The reverse fistula is attempted before using E-PTFE grafts. Upper extremity AV and AA loops can then be constructed de novo or from the reverse fistula.
针对肾衰竭患者独特的血管通路问题,有效的解决方法是在840例血管通路手术的五年经验基础上发展而来的。标准技术加上创新手段,每位患者每年仅需0.62次手术,平均通路使用寿命为1.6年。经典的前臂外动静脉(AV)插管和内AV瘘为392例患者提供了血管通路,而61例患者由于初次插管和瘘管失败、前臂血管本身细小以及医源性血管损失,需要更复杂的手术。二次技术包括反向瘘、使用膨体聚四氟乙烯(E-PTFE)的血管移植AV瘘和动脉-动脉(AA)搭桥移植。目前,新的肾衰竭患者接受前臂桡动脉-头静脉AV瘘;该插管仅限于紧急或短期血液透析,之后可能会转换为皮下瘘。在使用E-PTFE移植物之前尝试反向瘘。然后可以重新构建上肢AV和AA袢,或从前臂反向瘘构建。